Cécile Dorange

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.5K citations · Full text

Life Sciences, Oncology, Pharmacotherapy +17

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

Patrick W. Serruys, John A. Ormiston, Yoshinobu Onuma et al. · The Lancet · 2009 · 817 citations

Medicine, Cardiology, Surgery +14

CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer

Yelena Y. Janjigian, Johanna C. Bendell, Emiliano Calvo et al. · Journal of Clinical Oncology · 2018 · 631 citations · Full text

Medicine, Oncology, Pharmacology +16

Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis

Patrick W. Serruys, Yoshinobu Onuma, Dariusz Dudek et al. · Journal of the American College of Cardiology · 2011 · 525 citations

Medicine, Cardiology, Surgery +14

Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis

Patrick W. Serruys, Yoshinobu Onuma, John A. Ormiston et al. · Circulation · 2010 · 306 citations · Full text

Medicine, Bioengineering, Cardiology +17